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Aim: To study cytotoxicity of cisplatin conjugated with magnetic fluid (nanocomposite) upon exposure to magnetic field on sensitive 
and resistant to cisplatin MCF-7 human breast cancer cells. Methods: Cytotoxic activity was evaluated by MTT-test, intracel-
lular iron accumulation was analyzed cytochemically, genotoxicity was studied by micronucleus test and DNA comet assay, ultra-
structure was studied by electron microscopy techniques. Results: Nanocomposite of cisplatin was more toxic to MCF-7/S and 
MCF-7/CP cells compared to cisplatin in conventional pharmaceutical form. In nanocomposite-treated cells we observed more 
expressed signs of dystrophy (especially following application of magnetic field) and drastic alterations of nuclei ultrastructure with 
significant accumulation of iron nanoparticle clusters. The potent toxic action of nanocomposite is confirmed by electron microscopy 
and by marked genotoxicity, especially against MCF-7/CP cells. Conclusion: The enhancement of cyto- and genotoxicity of cis-
platin nanocomposite combined with magnetic field in comparison with effect of convetntional cisplatin alone was demonstrated.
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Recently t�e development of various nanotec�no-
logical platforms t�at may be useful in diagnosis and 
t�erapy �as become t�e focus of interest. T�e nano-
materials for targeted drug delivery into cells and 
tissues are especially important in oncology [�� �]. T�e 
development of targeted delivery of anticancer drugs 
is a topical problem taking into account t�eir low se-
lectivity as well as systemic toxicity. Up-to-date �ig�-
tec�nological products based on biocompatible 
nanocomposites of “magnetite — biocompatible 
coating — anticancer drug” type are important for t�e 
development of novel p�armaceutical tec�nologies 
allowing to en�ance t�e t�erapeutic effects and de-
crease t�e doses providing in turn t�e improving 
safety of anticancer t�erapy [�].
T�e concept of using micro- or nanoparticles for 
targeted delivery of drugs �as been put forward in late 
7�s by K.J. Widder et al.� A.E. Sinyei et al. [4� �]. T�e 
ways of targeted delivery of medicinal products pro-
vide optimal concentrations of t�e drugs in tumor wit� 
decreasing systemic toxic effects. Nanomaterials are 
of �ig� interest since t�e basic properties of traditional 
materials c�ange drastically upon t�eir transition into 
ultradispersed state and even new patterns develop 
[6]. T�e principal reason of suc� alterations wit� de-
creasing particle size consists in relative increase in t�e 
percentage of “surface” atoms and �ig�er contribu-
tion of surface energy in t�e overall c�emical potential 
[7]. Unique properties of nanoparticles suc� as small 
size� �ig� surface energy� biocompatibility� presence 
of magnetic properties open wide prospects for t�e 
use of nanomaterials in cancer t�erapy [8� �].
T�e advantages of nanomaterials for clinical ap-
plication are based not only on t�eir p�ysical proper-
ties� but also on t�e possibility of t�eir conjugation 
wit� medicinal products providing for t�e release and 
targeted delivery of active ingredients upon t�e de-
struction of suc� complexes wit� minimal toxicity for 
t�e organism. It is also important t�at ferromagnetics� 
t�e compounds possessing spontaneous magnetiza-
tion� are of significant interest as vectors for delivery 
of medicinal products for cancer treatment [��� ��].
T�e magnetic fluid representing a stable colloid dis-
persion of magnetic nanoparticles is t�e most custo-
mized nanotec�nological product for targeted delivery 
of cytostatics [��]. T�e unique properties of magnetic 
fluids could be varied by c�anging t�e composition� 
coating� s�ape and sizes of nanoparticles [��� �4]. 
It is also important t�at t�e use of static magnetic field 
�S�F� could transform magnetic fluid in a unique vec-
tor system providing targeted delivery of nanoparticle 
composite to t�e malignant foci. S�F �as been s�own 
to affect membrane permeability resulting in elevated 
accumulation of nanocomposite �NC� containing anti-
cancer drugs [��� �6]. T�is effect could be promising 
for overcoming drug resistance to different cytosta tics� 
especially cisplatin �CP�� w�ic� is one of t�e drugs 
of c�oice in breast cancer treatment.
Above-mentioned facts evidence on t�e necessity 
to study t�e mec�anism of modification of cytotoxic 
activity of NC of CP wit� magnetic fluid and S�F as fac-
tors improving selectivity of t�e cytostatic agents and 
overcoming drug resistance.
MATERIALS AND METHODS
Object of study. T�e biological activity of NC and S�F 
was studied on sensitive and resistant to CP �CF-7 �u-
man breast cancer cells ��CF-7/S and �CF-7/CP�. Cells 
were cultivated in modified Dulbecco ISCOV �“Sigma”� 
Germany� culture medium supplemented wit� ��% fetal 
calf serum �“Sangva”� Ukraine� at �7 оС in �% СО� atmo-
sp�ere. Cells were reseeded twice a week at seeding 
density of ��4x��4 cells/cm� w�en t�e cells reac�ed 
��% of confluence.
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Resistance to CP in �CF-7 cell line was deve-
loped by cultivation of �CF-7 cells in medium wit� 
rising concentrations of CP. Eac� two mont�s cell 
resistance was analyzed by �TT-test. Index of re-
sistance to CP in �CF-7/CP cells was 4. CP IC�� for 
�CF-7/S and �CF-7/CP cells were equal to � and 
6 μg/ml respectively.
NC of magnetic fluid wit� CP were prepared 
and kindly provided for t�e study by t�e scientists 
of t�e А.А. C�uyko Institute of Surface C�emistry� 
NAS of Ukraine.
S�F ���� mT� was generated by two parallel mag-
nets. Induction of S�F was measured at t�e center 
of t�e system.
Study design. CP in conventional p�armaceu-
tical form �“Ebewe”� Austria� and NC were added 
into culture medium for �4 �. ��� mT S�F was ap-
plied for � �. T�e contents of iron and CP in NC were 
� mg/ml� and ��� μg/ml respectively. T�e doses for 
�TT test were calculated based on CP content in t�e 
range of �.��7.� μg/ml. For furt�er experiments t�e 
IC�� NC concentration of �.� μg/ml was c�osen for 
�CF-7/S cells and �.� μg/ml for �CF-7/CP. At t�ese 
doses t�e drug did not cause t�e increase of t�e num-
ber of dead cells. Nevert�eless� t�e alterations in cell 
ultrastructure due to t�eir toxic effects are evident.
Determination of cytotoxic activity. Cytotoxicity 
of CP and NC after �4-� exposure on �CF-7/S and 
�CF-7/CP cells was estimated by standard МТТ-test 
wit� �-[4��-dimet�ylt�iazol-���]-���-dip�enyltetraso-
lium bromide �“Sigma”� Germany�.
The study of accumulation of NC by MCF-7 cells. 
NC accumulation in �CF-7/S and �CF/CP �uman 
breast cancer cells was studied by identification of mag-
netic fluid nanoparticles by modified Lilli met�od [�7].
Electron microscopy. Cells were fixed in �.6% 
glutaralde�yde solution in �.� М cacodylate buffer 
�рН 7.�� for � �� and t�en was�ed in �.� М cacodyl-
ate buffer for �6��8 �. To ac�ieve optimal isotonicity 
of fixing and was�ing buffers� cacodylate buffer was 
supplemented wit� sacc�arose ��� mg/ml�. Postfix-
ation of t�e cells was done in �% osmium tetroxide� wit� 
following de�ydration in alco�ols� and t�e preparations 
were embedded in epoxide by standard tec�nique. 
Ultrat�in slides prepared on LKB-88�� ultratome were 
contrasted wit� uranyl acetate and plumbous citrate 
and studied in electron microscope JE�-���B �“JEOL”� 
Japan� at accelerated voltage of 8� кV.
DNA Comet Assay. DNA comet assay was per-
formed according to t�e classic alkaline single-cell 
electrop�oresis protocol [�8]. Samples were stained 
wit� SYBR Green I �“Sigma”� Germany� and analyzed 
by CometScore �.� software. Percent of DNA in comet 
tails was considered as t�e marker of genotoxic effect.
Micronucleus test. �icronucleus test ��N-test� 
was performed according to Hayas�i et al. [��] wit� 
staining by �% acridine orange. We counted number 
of �N per ���� cells using luminescent microscopy.
Statistical analysis. Statistical analysis was per-
formed using STATISTIСA 6.� software. Differences 
between obtained values were studied using Stu-
dent’s t-test. Differences were considered significant 
in case of р < ����.
RESULTS AND DISCUSSION
Cytotoxicity of CP and NC on MCF-7 cells. We �ave 
found t�at NC demonstrated �ig�er cytotoxic effect t�an 
t�at of t�e conventional form of CP �Fig. ��. IC�� of con-
ventional form of CP for �CF-7/S cells was � μg/ml� w�ile 
IC�� of NC was � μg/ml.
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Fig. 1. Cytotoxic influence of CP and NC on �CF-7/S and 
�CF-7/CP cells
Analysis of NC accumulation in �CF-7 �uman 
breast cancer cells by visualization of nanoparticles 
using modified Lilli met�od s�owed several differences 
between sensitive and resistant cell lines. Total number 
of �CF-7/CP cells wit� NC nanoparticles and average 
number of nanoparticles per cell� t�eir density and dimen-
sions were greater compared to t�ose in �CF-7/S cells. 
Also we found t�at resistant �CF-7 cells� w�ic� over-
accumulated NC� were c�aracterized by muc� �ig�er 
NC activity: generation of “t�erapeutic giants” and cell 
deat� due to necrobiosis �Fig. ��.
We found several features of cytotoxic action 
of NC on ultrastructural organization of �CF-7/S and 
�CF-7/CP cells. �CF-7/S cells s�owed dystrop�ic 
c�anges� necrobiosis and cell deat� due to necrosis. 
�yelin figures and big comlex lysosomes wit� cell 
detritus and NC particles appeared in cytoplasm.
Also� sensitive cells after NC treatment s�owed 
nuclear membrane invaginations and loss of nucleoli. 
Cell cytoplasm was c�aracterized by roug� endoplas-
matic reticulum �ER� enlargement� presented by round 
c�annels and cavities situated close to mitoc�ondria� 
appearance of multilocus Golgi apparatus and elevation 
of number of p�agosome wit� NC nanoparticles �Fig. ��.
Localization of NC nanoparticles in nucleus caused 
elevation of euc�romatin and reduction of �eteroc�ro-
matin fractions.
T�ese c�anges mig�t be a result of small size 
of NC particles w�at allowed t�em to penetrate not only 
to cytoplasm but also into cell nuclei. After penetration 
into cells by endocytosis� nanoparticles concentrate 
in cytoplasm in endocytosis vesicles adjacent to lyso-
somes. Cells ultrastructure complication �elps furt�er 
internalization of nanoparticles into cells.
It s�ould be mentioned t�at combined action 
of NC and S�F caused elevation of �CF-7/S dead cells 
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number pointing on amplifying effect of S�F. W�ile most 
part of cells died due to necrosis� we found cells wit� ul-
trastuctural features of apoptosis and apoptotic bodies.
Fig. 3. C�anges in �CF-7/S cells after NC treatment. Enlarged 
roug� ER is presented by round c�annels and cavities situated 
close to mitoc�ondria. Electron microscopy. Х �� ���
�CF-7/CP cells s�owed more significant c�anges 
in t�eir ultrastructure compared to sensitive ones. 
We mentioned t�at nuclei of t�ese cells were electron-
transparent as a result of significant qualitative and 
quantitative c�anges of c�romatin structure wit� loss 
of �eteroc�romatin and elevation of euc�romatin 
regions �Fig. 4�.
Significant c�anges in nuclei of resistant cells mig�t 
be a result of NC accumulation� w�ic� could be a target 
for S�F t�at caused c�romatin disorganisation and� 
furt�er� cell deat�. We also found significant c�anges 
in cytoplasm ultrastructure of resistant cells: multiple 
vacuolization of cytoplasm on cell organelles� espe-
cially mitoc�ondria �Fig. ��.
Fig. 4. C�anges in nuclear c�romatin ultrastructure 
in �CF-7/CP cells wit� �ig� accumulation of NC particles. 
Electron microscopy. Х �� ���
S�F enforced cytotoxic effects in �CF-7/CP cells 
compared to sensitive ones because of elevated ac-
cumulation of NC nanoparticles in cells. T�is caused 
elevation of number of dystrop�ically c�anged and 
dying cells. �4% of cells were dead after combined ac-
tion of NC and S�F� and t�e most part of t�em �almost 
��%� were dead due to apoptosis �Fig. 6�.
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Fig. 2. Histoc�emical visualization of NC particles in �CF-7 cells by modified Lilli met�od� x���� oil immersion. a — Several 
NC nanoparticles found in �CF-7/S cells cytoplasm. b — �CF-7/S cells wit� separate and enlarged granules of NC particles. c — 
�CF-7/CP cells wit� big number of NC nanogranules� “t�erapeutic giant” wit� many small dense granules. d — �CF-7/CP cells 
in necrobiotic deat� due to overaccumulation of large dense granules of NC
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Fig. 5. Significant vacuole-�ydropic dystrop�y in t�e cytoplasm 
of �CF-7/CP cells after combined effect of NC particles accu-
mulation and S�F. Electron microscopy. Х �� ���
Fig. 6. Deat� of �CF-7/CP cell due to apoptosis as a result 
of NC and S�F combined effect. Electron microscopy. Х �� ���
Studies of genotoxic effect of NC and its combined 
action wit� S�F was performed by �N-test and DNA 
comet assay �Fig. 7�.
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Fig. 7. Genotoxic effect of NC and its combination wit� S�F 
against �CF-7/S and �CF-7/Dox cells. DNA comet assay
Significant elevation of tested parameters 
�number of micronuclei� % of DNA in comet tails� 
in �CF-7/S cells after NC and NC+S�F treatment 
compared to control was observed �Table�.
Studies of genotoxic effects of NC and its combined 
action wit� S�F on �CF-7/CP cells s�owed t�at num-
ber of �N and percent of DNA in comet tails after bot� 
agents were �ig�er compared to �CF-7/S correspond-
ing values �Table�. It s�ould be mentioned t�at control 
values for bot� parameters in resistant cells were signifi-
cantly �ig�er compared to t�ose for �CF-7/S cells. So� 
presence of NC in cultivation medium caused significant 
elevation of genotoxic effects not only in sensitive but 
also in resistant to CP �CF-7 cells. Combination wit� 
S�F slig�tly increased t�e observed effects.
Table. Percent of DNA in comet tails after impact of studied factors
Cell line
Control NC NC+SMF
MN, ‰
of DNA 
in comet 
tails, %
MN, ‰
of DNA 
in comet 
tails, %
MN, ‰
of DNA 
in comet 
tails, %
MCF-7/S 4.8±0.2 3.2±0.2 19.2±1.4* 5.7±0.6* 21.2±1.2* 6.8±0.8*
MCF-7/CP 10.8±1.1** 3.0±0.1 25.2±1.3** 7.9±0.5** 27.2±1.4** 10.1±0.6**
Notes: *significantly higher (p<0.05) compared to control; **significantly 
higher compared to control and MCF-7/S cells with corresponding impact.
T�e obtained data s�ow t�at NC incorporation into �CF-
7/CP cells compared to �CF-7/S cells is muc� more ac-
tive. It is proved by results of �istoc�emical staining of mag-
netic fluid nanoparticles w�ic� were t�e part of NC and mi-
croscopy studies of nanoparticles in �CF-7 cells. NC �ad 
�ig�er cytotoxic effect compared to CP against bot� 
�CF-7/S and �CF-7/CP cells. IC�� for CP against �CF-
7/S cells is ��� μg/ml� w�ile IC�� for NC was ��� μg/ml.
Cytomorp�ology and electron microscopy of resis-
tant cells wit� �ig� levels of accumulated NC s�owed 
its �ig�er cytotoxic effects in particular dystrop�y� 
necrobiosis� necrosis and apoptosis. External S�F 
caused elevation of NC cytotoxicity especially 
against �CF-7/CP cells. NC and its combination 
wit� S�F caused significant genotoxic effects bot� 
in �CF-7/S and especially in �CF-7/CP cells.
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